HEADER TRANSFERASE 01-JUL-10 2XJ2
TITLE PROTEIN KINASE PIM-1 IN COMPLEX WITH SMALL MOLECULE INHIBITOR
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: PROTO-ONCOGENE SERINE/THREONINE-PROTEIN KINASE PIM-1;
COMPND 3 CHAIN: A;
COMPND 4 FRAGMENT: KINASE DOMAIN, RESIDUES 14-313;
COMPND 5 EC: 2.7.11.1;
COMPND 6 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: PIM1;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562;
SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;
SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET30A
KEYWDS TRANSFERASE, PHOSPHORYLATION, PROTEIN KINASE FOLD
EXPDTA X-RAY DIFFRACTION
AUTHOR M.N.SCHULZ,J.FANGHANEL,M.SCHAFER,V.BADOCK,H.BRIEM,U.BOEMER,D.NGUYEN,
AUTHOR 2 M.HUSEMANN,R.C.HILLIG
REVDAT 4 16-OCT-24 2XJ2 1 REMARK
REVDAT 3 01-MAY-24 2XJ2 1 REMARK LINK
REVDAT 2 16-MAR-11 2XJ2 1 JRNL
REVDAT 1 23-FEB-11 2XJ2 0
JRNL AUTH M.N.SCHULZ,J.FANGHANEL,M.SCHAFER,V.BADOCK,H.BRIEM,U.BOEMER,
JRNL AUTH 2 D.NGUYEN,M.HUSEMANN,R.C.HILLIG
JRNL TITL CRYSTALLOGRAPHIC FRAGMENT SCREEN IDENTIFIES CINNAMIC ACID
JRNL TITL 2 DERIVATIVES AS STARTING POINTS FOR POTENT PIM-1 INHIBITORS
JRNL REF ACTA CRYSTALLOGR.,SECT.D V. 67 156 2011
JRNL REFN ISSN 0907-4449
JRNL PMID 21358046
JRNL DOI 10.1107/S0907444910054144
REMARK 2
REMARK 2 RESOLUTION. 2.20 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : REFMAC 5.2.0019
REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER,
REMARK 3 : NICHOLLS,WINN,LONG,VAGIN
REMARK 3
REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.59
REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL
REMARK 3 COMPLETENESS FOR RANGE (%) : 97.7
REMARK 3 NUMBER OF REFLECTIONS : 20051
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.169
REMARK 3 R VALUE (WORKING SET) : 0.167
REMARK 3 FREE R VALUE : 0.202
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100
REMARK 3 FREE R VALUE TEST SET COUNT : 1067
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 20
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.26
REMARK 3 REFLECTION IN BIN (WORKING SET) : 1190
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 78.84
REMARK 3 BIN R VALUE (WORKING SET) : 0.2130
REMARK 3 BIN FREE R VALUE SET COUNT : 58
REMARK 3 BIN FREE R VALUE : 0.3280
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 2234
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 25
REMARK 3 SOLVENT ATOMS : 148
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 22.20
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : 0.29000
REMARK 3 B22 (A**2) : 0.29000
REMARK 3 B33 (A**2) : -0.44000
REMARK 3 B12 (A**2) : 0.15000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED OVERALL COORDINATE ERROR.
REMARK 3 ESU BASED ON R VALUE (A): 0.184
REMARK 3 ESU BASED ON FREE R VALUE (A): 0.159
REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.115
REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 8.585
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.961
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.950
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT
REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2354 ; 0.010 ; 0.021
REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL
REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3199 ; 1.200 ; 1.963
REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL
REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 279 ; 5.615 ; 5.000
REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 122 ;34.677 ;22.869
REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 391 ;14.673 ;15.038
REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 24 ;21.627 ;15.000
REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 336 ; 0.079 ; 0.200
REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1840 ; 0.004 ; 0.020
REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1053 ; 0.188 ; 0.200
REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1587 ; 0.303 ; 0.200
REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 145 ; 0.125 ; 0.200
REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 31 ; 0.133 ; 0.200
REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 11 ; 0.126 ; 0.200
REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1429 ; 1.857 ; 2.000
REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2240 ; 2.814 ; 3.000
REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1068 ; 4.549 ; 4.500
REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 958 ; 6.403 ; 6.000
REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3
REMARK 3 NCS RESTRAINTS STATISTICS
REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : 2
REMARK 3
REMARK 3 TLS GROUP : 1
REMARK 3 NUMBER OF COMPONENTS GROUP : 1
REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI
REMARK 3 RESIDUE RANGE : A 33 A 123
REMARK 3 ORIGIN FOR THE GROUP (A): -16.2830 -33.3950 7.6060
REMARK 3 T TENSOR
REMARK 3 T11: -0.0307 T22: 0.0932
REMARK 3 T33: -0.1520 T12: 0.0788
REMARK 3 T13: -0.0580 T23: 0.0010
REMARK 3 L TENSOR
REMARK 3 L11: 9.0675 L22: 3.3864
REMARK 3 L33: 5.0149 L12: -0.4605
REMARK 3 L13: 0.0045 L23: 0.7447
REMARK 3 S TENSOR
REMARK 3 S11: 0.0451 S12: -0.5880 S13: -0.2823
REMARK 3 S21: 0.3490 S22: 0.0673 S23: -0.3141
REMARK 3 S31: 0.0150 S32: 0.6770 S33: -0.1124
REMARK 3
REMARK 3 TLS GROUP : 2
REMARK 3 NUMBER OF COMPONENTS GROUP : 1
REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI
REMARK 3 RESIDUE RANGE : A 124 A 306
REMARK 3 ORIGIN FOR THE GROUP (A): -36.6900 -24.5090 -3.4550
REMARK 3 T TENSOR
REMARK 3 T11: -0.1060 T22: -0.0997
REMARK 3 T33: -0.2662 T12: 0.0306
REMARK 3 T13: 0.0272 T23: -0.0104
REMARK 3 L TENSOR
REMARK 3 L11: 2.0340 L22: 2.2754
REMARK 3 L33: 2.5821 L12: 0.3144
REMARK 3 L13: 0.8813 L23: -0.1838
REMARK 3 S TENSOR
REMARK 3 S11: -0.0627 S12: 0.0620 S13: -0.0361
REMARK 3 S21: -0.0534 S22: 0.1179 S23: -0.0236
REMARK 3 S31: 0.0182 S32: 0.0348 S33: -0.0552
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : MASK
REMARK 3 PARAMETERS FOR MASK CALCULATION
REMARK 3 VDW PROBE RADIUS : 1.40
REMARK 3 ION PROBE RADIUS : 0.80
REMARK 3 SHRINKAGE RADIUS : 0.80
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING
REMARK 3 POSITIONS.
REMARK 4
REMARK 4 2XJ2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 01-JUL-10.
REMARK 100 THE DEPOSITION ID IS D_1290044474.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 19-JUN-08
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 5.75
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : BESSY
REMARK 200 BEAMLINE : 14.2
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 0.91841
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000
REMARK 200 DATA SCALING SOFTWARE : HKL-2000
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21150
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200
REMARK 200 RESOLUTION RANGE LOW (A) : 41.600
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 97.7
REMARK 200 DATA REDUNDANCY : 10.50
REMARK 200 R MERGE (I) : 0.10000
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 23.4000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.27
REMARK 200 COMPLETENESS FOR SHELL (%) : 80.3
REMARK 200 DATA REDUNDANCY IN SHELL : 6.20
REMARK 200 R MERGE FOR SHELL (I) : 0.48000
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.600
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: REFMAC
REMARK 200 STARTING MODEL: IN-HOUSE PIM-1 STRUCTURE
REMARK 200
REMARK 200 REMARK: SOLVED BY RIGID BODY REFINEMENT
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 62.80
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.28
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 0.8 M (NH4)2HPO4, 0.1 M SODIUM CITRATE
REMARK 280 PH 5.75, 0.2 M NACL
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 65
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -Y,X-Y,Z+2/3
REMARK 290 3555 -X+Y,-X,Z+1/3
REMARK 290 4555 -X,-Y,Z+1/2
REMARK 290 5555 Y,-X+Y,Z+1/6
REMARK 290 6555 X-Y,X,Z+5/6
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000
REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 53.85667
REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000
REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000
REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 26.92833
REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 40.39250
REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000
REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000
REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 13.46417
REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000
REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000
REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 67.32083
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 GLY A 13
REMARK 465 ALA A 14
REMARK 465 ALA A 15
REMARK 465 PRO A 16
REMARK 465 CYS A 17
REMARK 465 ASN A 18
REMARK 465 ASP A 19
REMARK 465 LEU A 20
REMARK 465 HIS A 21
REMARK 465 ALA A 22
REMARK 465 THR A 23
REMARK 465 LYS A 24
REMARK 465 LEU A 25
REMARK 465 ALA A 26
REMARK 465 PRO A 27
REMARK 465 GLY A 28
REMARK 465 LYS A 29
REMARK 465 GLU A 30
REMARK 465 LYS A 31
REMARK 465 GLU A 32
REMARK 465 LEU A 307
REMARK 465 SER A 308
REMARK 465 PRO A 309
REMARK 465 GLY A 310
REMARK 465 PRO A 311
REMARK 465 SER A 312
REMARK 465 LYS A 313
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 PRO A 81 -6.10 -53.26
REMARK 500 ASP A 167 44.73 -143.41
REMARK 500 ASP A 186 82.15 56.84
REMARK 500 ASP A 202 24.44 -147.43
REMARK 500 HIS A 305 -32.68 73.50
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 985 A 1001
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 2BIK RELATED DB: PDB
REMARK 900 HUMAN PIM1 PHOSPHORYLATED ON SER261
REMARK 900 RELATED ID: 2XIX RELATED DB: PDB
REMARK 900 PROTEIN KINASE PIM-1 IN COMPLEX WITH FRAGMENT-1 FROM
REMARK 900 CRYSTALLOGRAPHIC FRAGMENT SCREEN
REMARK 900 RELATED ID: 1YWV RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURES OF PROTO-ONCOGENE KINASE PIM1: A TARGETOF
REMARK 900 ABERRANT SOMATIC HYPERMUTATIONS IN DIFFUSE LARGE CELLLYMPHOMA
REMARK 900 RELATED ID: 2BZJ RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN PIM1 IN COMPLEX WITH A RUTHENIUM
REMARK 900 ORGANOMETALLIC LIGAND RU3
REMARK 900 RELATED ID: 2C3I RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF HUMAN PIM1 IN COMPLEX WITH IMIDAZOPYRIDAZIN I
REMARK 900 RELATED ID: 1YXU RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF KINASE PIM1 IN COMPLEX WITH AMP
REMARK 900 RELATED ID: 2J2I RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF THE HUMAB PIM1 IN COMPLEX WITH LY333531
REMARK 900 RELATED ID: 1YXT RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF KINASE PIM1 IN COMPLEX WITH AMPPNP
REMARK 900 RELATED ID: 2BZH RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN PIM1 IN COMPLEX WITH A RUTHENIUM
REMARK 900 ORGANOMETALLIC LIGAND RU1
REMARK 900 RELATED ID: 1YXS RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF KINASE PIM1 WITH P123M MUTATION
REMARK 900 RELATED ID: 1XQZ RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF HPIM-1 KINASE AT 2.1 A RESOLUTION
REMARK 900 RELATED ID: 1YI3 RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF PIM-1 BOUND TO LY294002
REMARK 900 RELATED ID: 1YXV RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF KINASE PIM1 IN COMPLEX WITH 3,4 -DIHYDROXY-1-
REMARK 900 METHYLQUINOLIN-2(1H)-ONE
REMARK 900 RELATED ID: 2XIZ RELATED DB: PDB
REMARK 900 PROTEIN KINASE PIM-1 IN COMPLEX WITH FRAGMENT-3 FROM
REMARK 900 CRYSTALLOGRAPHIC FRAGMENT SCREEN
REMARK 900 RELATED ID: 1XR1 RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF HPIM-1 KINASE IN COMPLEX WITH AMP-PNPAT 2.1 A
REMARK 900 RESOLUTION
REMARK 900 RELATED ID: 2XIY RELATED DB: PDB
REMARK 900 PROTEIN KINASE PIM-1 IN COMPLEX WITH FRAGMENT-2 FROM
REMARK 900 CRYSTALLOGRAPHIC FRAGMENT SCREEN
REMARK 900 RELATED ID: 2BIL RELATED DB: PDB
REMARK 900 THE HUMAN PROTEIN KINASE PIM1 IN COMPLEX WITH ITS CONSENSUS PEPTIDE
REMARK 900 PIMTIDE
REMARK 900 RELATED ID: 1YHS RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF PIM-1 BOUND TO STAUROSPORINE
REMARK 900 RELATED ID: 1XWS RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN PIM1 KINASE DOMAIN
REMARK 900 RELATED ID: 1YXX RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF KINASE PIM1 IN COMPLEX WITH (3E )-3-[(4-
REMARK 900 HYDROXYPHENYL)IMINO]-1H-INDOL-2(3H)-ONE
REMARK 900 RELATED ID: 2BZK RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN PIM1 IN COMPLEX WITH AMPPNP AND
REMARK 900 PIMTIDE
REMARK 900 RELATED ID: 2XJ1 RELATED DB: PDB
REMARK 900 PROTEIN KINASE PIM-1 IN COMPLEX WITH SMALL MOLECULE INIBITOR
REMARK 900 RELATED ID: 2XJ0 RELATED DB: PDB
REMARK 900 PROTEIN KINASE PIM-1 IN COMPLEX WITH FRAGMENT-4 FROM
REMARK 900 CRYSTALLOGRAPHIC FRAGMENT SCREEN
REMARK 900 RELATED ID: 1YI4 RELATED DB: PDB
REMARK 900 STRUCTURE OF PIM-1 BOUND TO ADENOSINE
REMARK 900 RELATED ID: 2BZI RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN PIM1 IN COMPLEX WITH A RUTHENIUM
REMARK 900 ORGANOMETALLIC LIGAND RU2
REMARK 999
REMARK 999 SEQUENCE
REMARK 999 N-TERMINAL GLY FROM TEV CLEAVAGE SITE
DBREF 2XJ2 A 14 313 UNP P11309 PIM1_HUMAN 14 313
SEQADV 2XJ2 GLY A 13 UNP P11309 EXPRESSION TAG
SEQRES 1 A 301 GLY ALA ALA PRO CYS ASN ASP LEU HIS ALA THR LYS LEU
SEQRES 2 A 301 ALA PRO GLY LYS GLU LYS GLU PRO LEU GLU SER GLN TYR
SEQRES 3 A 301 GLN VAL GLY PRO LEU LEU GLY SER GLY GLY PHE GLY SER
SEQRES 4 A 301 VAL TYR SER GLY ILE ARG VAL SER ASP ASN LEU PRO VAL
SEQRES 5 A 301 ALA ILE LYS HIS VAL GLU LYS ASP ARG ILE SER ASP TRP
SEQRES 6 A 301 GLY GLU LEU PRO ASN GLY THR ARG VAL PRO MET GLU VAL
SEQRES 7 A 301 VAL LEU LEU LYS LYS VAL SER SER GLY PHE SER GLY VAL
SEQRES 8 A 301 ILE ARG LEU LEU ASP TRP PHE GLU ARG PRO ASP SER PHE
SEQRES 9 A 301 VAL LEU ILE LEU GLU ARG PRO GLU PRO VAL GLN ASP LEU
SEQRES 10 A 301 PHE ASP PHE ILE THR GLU ARG GLY ALA LEU GLN GLU GLU
SEQRES 11 A 301 LEU ALA ARG SER PHE PHE TRP GLN VAL LEU GLU ALA VAL
SEQRES 12 A 301 ARG HIS CYS HIS ASN CYS GLY VAL LEU HIS ARG ASP ILE
SEQRES 13 A 301 LYS ASP GLU ASN ILE LEU ILE ASP LEU ASN ARG GLY GLU
SEQRES 14 A 301 LEU LYS LEU ILE ASP PHE GLY SER GLY ALA LEU LEU LYS
SEQRES 15 A 301 ASP THR VAL TYR THR ASP PHE ASP GLY THR ARG VAL TYR
SEQRES 16 A 301 SER PRO PRO GLU TRP ILE ARG TYR HIS ARG TYR HIS GLY
SEQRES 17 A 301 ARG SER ALA ALA VAL TRP SER LEU GLY ILE LEU LEU TYR
SEQRES 18 A 301 ASP MET VAL CYS GLY ASP ILE PRO PHE GLU HIS ASP GLU
SEQRES 19 A 301 GLU ILE ILE ARG GLY GLN VAL PHE PHE ARG GLN ARG VAL
SEQRES 20 A 301 SER SEP GLU CYS GLN HIS LEU ILE ARG TRP CYS LEU ALA
SEQRES 21 A 301 LEU ARG PRO SER ASP ARG PRO THR PHE GLU GLU ILE GLN
SEQRES 22 A 301 ASN HIS PRO TRP MET GLN ASP VAL LEU LEU PRO GLN GLU
SEQRES 23 A 301 THR ALA GLU ILE HIS LEU HIS SER LEU SER PRO GLY PRO
SEQRES 24 A 301 SER LYS
MODRES 2XJ2 SEP A 261 SER PHOSPHOSERINE
HET SEP A 261 10
HET 985 A1001 25
HETNAM SEP PHOSPHOSERINE
HETNAM 985 (2E)-3-{3-[6-(4-METHYL-1,4-DIAZEPAN-1-YL)PYRAZIN-2-
HETNAM 2 985 YL]PHENYL}PROP-2-ENOIC ACID
HETSYN SEP PHOSPHONOSERINE
FORMUL 1 SEP C3 H8 N O6 P
FORMUL 2 985 C19 H22 N4 O2
FORMUL 3 HOH *148(H2 O)
HELIX 1 1 ASP A 72 ILE A 74 5 3
HELIX 2 2 MET A 88 SER A 97 1 10
HELIX 3 3 LEU A 129 GLY A 137 1 9
HELIX 4 4 GLN A 140 CYS A 161 1 22
HELIX 5 5 LYS A 169 GLU A 171 5 3
HELIX 6 6 THR A 204 SER A 208 5 5
HELIX 7 7 PRO A 209 HIS A 216 1 8
HELIX 8 8 HIS A 219 GLY A 238 1 20
HELIX 9 9 HIS A 244 GLY A 251 1 8
HELIX 10 10 SER A 260 LEU A 271 1 12
HELIX 11 11 ARG A 274 ARG A 278 5 5
HELIX 12 12 THR A 280 ASN A 286 1 7
HELIX 13 13 HIS A 287 GLN A 291 5 5
HELIX 14 14 LEU A 295 LEU A 304 1 10
SHEET 1 A 5 TYR A 38 GLY A 47 0
SHEET 2 A 5 GLY A 50 ARG A 57 -1 O SER A 54 N GLY A 41
SHEET 3 A 5 PRO A 63 GLU A 70 -1 O VAL A 64 N GLY A 55
SHEET 4 A 5 SER A 115 GLU A 121 -1 O LEU A 120 N ALA A 65
SHEET 5 A 5 LEU A 106 GLU A 111 -1 N LEU A 107 O ILE A 119
SHEET 1 B 2 TRP A 77 GLU A 79 0
SHEET 2 B 2 ARG A 85 PRO A 87 -1 O VAL A 86 N GLY A 78
SHEET 1 C 3 VAL A 126 ASP A 128 0
SHEET 2 C 3 ILE A 173 ASP A 176 -1 O ILE A 175 N GLN A 127
SHEET 3 C 3 GLU A 181 LEU A 184 -1 O GLU A 181 N ASP A 176
SHEET 1 D 2 VAL A 163 LEU A 164 0
SHEET 2 D 2 ALA A 191 LEU A 192 -1 O ALA A 191 N LEU A 164
LINK C SER A 260 N SEP A 261 1555 1555 1.33
LINK C SEP A 261 N GLU A 262 1555 1555 1.33
CISPEP 1 PRO A 33 LEU A 34 0 -6.80
CISPEP 2 GLU A 124 PRO A 125 0 -1.31
SITE 1 AC1 14 LEU A 44 ALA A 65 LYS A 67 LEU A 120
SITE 2 AC1 14 GLU A 121 ASP A 128 GLU A 171 ASN A 172
SITE 3 AC1 14 LEU A 174 ILE A 185 ASP A 186 HOH A2020
SITE 4 AC1 14 HOH A2071 HOH A2147
CRYST1 96.167 96.167 80.785 90.00 90.00 120.00 P 65 6
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.010399 0.006004 0.000000 0.00000
SCALE2 0.000000 0.012007 0.000000 0.00000
SCALE3 0.000000 0.000000 0.012379 0.00000